ProShare Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.24M Sell
90,362
-22,175
-20% -$1.83M 0.01% 405
2025
Q4
$9.59M Buy
112,537
+8,266
+8% +$678K 0.02% 354
2025
Q3
$8.11M Sell
104,271
-1,673
-2% -$131K 0.02% 376
2025
Q2
$8.29M Buy
105,944
+10,976
+12% +$819K 0.02% 366
2025
Q1
$6.88M Buy
94,968
+4,300
+5% +$308K 0.02% 456
2024
Q4
$6.71M Buy
90,668
+8,491
+10% +$594K 0.02% 463
2024
Q3
$5.42M Sell
82,177
-6,388
-7% -$464K 0.01% 507
2024
Q2
$8.18M Buy
88,565
+5,944
+7% +$526K 0.02% 348
2024
Q1
$7.9M Sell
82,621
-2,221
-3% -$187K 0.02% 412
2023
Q4
$6.47M Sell
84,842
-8,442
-9% -$587K 0.02% 449
2023
Q3
$6.46M Sell
93,284
-3,868
-4% -$311K 0.02% 441
2023
Q2
$9.16M Buy
97,152
+516
+0.5% +$44.8K 0.03% 325
2023
Q1
$7.99M Buy
+96,636
New +$7.6M 0.02% 401
2022
Q4
Sell
-84,397
Closed -$6.97M 1864
2022
Q3
$6.97M Sell
84,397
-9,887
-10% -$951K 0.03% 388
2022
Q2
$8.96M Sell
94,284
-37,663
-29% -$3.9M 0.03% 321
2022
Q1
$15.5M Sell
131,947
-3,768
-3% -$423K 0.03% 289
2021
Q4
$17.6M Buy
135,715
+30,751
+29% +$3.59M 0.03% 281
2021
Q3
$11.9M Sell
104,964
-2,268
-2% -$259K 0.03% 311
2021
Q2
$11.1M Buy
107,232
+15,203
+17% +$1.43M 0.03% 329
2021
Q1
$7.7M Buy
92,029
+4,710
+5% +$398K 0.02% 405
2020
Q4
$7.97M Buy
87,319
+8,736
+11% +$725K 0.03% 377
2020
Q3
$6.27M Sell
78,583
-17,214
-18% -$1.34M 0.03% 378
2020
Q2
$6.62M Sell
95,797
-3,854
-4% -$274K 0.04% 371
2020
Q1
$6.26M Sell
99,651
-53,853
-35% -$3.88M 0.05% 313
2019
Q4
$11.9M Buy
153,504
+66,435
+76% +$5.19M 0.06% 323
2019
Q3
$6.38M Sell
87,069
-3,459
-4% -$243K 0.04% 380
2019
Q2
$5.58M Sell
90,528
-15,405
-15% -$932K 0.03% 391
2019
Q1
$6.76M Buy
105,933
+3,783
+4% +$216K 0.04% 367
2018
Q4
$5.21M Sell
102,150
-45,285
-31% -$2.29M 0.04% 384
2018
Q3
$8.56M Sell
147,435
-5,613
-4% -$275K 0.06% 267
2018
Q2
$7.43M Sell
153,048
-3,300
-2% -$154K 0.05% 310
2018
Q1
$7.27M Buy
156,348
+3,669
+2% +$159K 0.05% 337
2017
Q4
$5.74M Buy
152,679
+17,259
+13% +$633K 0.04% 398
2017
Q3
$4.93M Buy
135,420
+37,299
+38% +$1.42M 0.05% 378
2017
Q2
$3.87M Sell
98,121
-1,557
-2% -$56.8K 0.04% 405
2017
Q1
$3.13M Buy
99,678
+22,845
+30% +$715K 0.03% 446
2016
Q4
$2.4M Buy
76,833
+26,010
+51% +$843K 0.03% 497
2016
Q3
$2.04M Sell
50,823
-25,692
-34% -$968K 0.03% 487
2016
Q2
$2.54M Buy
76,515
+354
+0.5% +$12.1K 0.03% 423
2016
Q1
$2.24M Sell
76,161
-55,155
-42% -$1.52M 0.03% 424
2015
Q4
$3.46M Sell
131,316
-36,162
-22% -$939K 0.04% 361
2015
Q3
$3.97M Sell
167,478
-8,796
-5% -$212K 0.06% 310
2015
Q2
$4.18M Sell
176,274
-13,176
-7% -$297K 0.06% 313
2015
Q1
$4.5M Sell
189,450
-12,174
-6% -$273K 0.05% 333
2014
Q4
$4.28M Buy
201,624
+39,912
+25% +$802K 0.05% 360
2014
Q3
$2.75M Buy
161,712
+17,370
+12% +$274K 0.04% 543
2014
Q2
$2.06M Sell
144,342
-9,204
-6% -$125K 0.03% 722
2014
Q1
$1.9M Buy
153,546
+9,198
+6% +$106K 0.02% 779
2013
Q4
$1.58M Buy
144,348
+77,916
+117% +$878K 0.02% 845
2013
Q3
$771K Sell
66,432
-45,726
-41% -$535K 0.02% 1074
2013
Q2
$1.26M Buy
+112,158
New +$1.33M 0.02% 704

Other funds holding EW